Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the supply of prescription medicines in (a) rural and (b) other areas.

Integrated care boards are responsible for understanding the health needs of their areas and commissioning services to meet those needs. Local authorities are required to undertake a pharmaceutical needs assessment every three years, to assess whether their population is adequately served, and must keep these assessments under review. These assessments inform integrated care boards when they are reviewing applications for National Health Service pharmacies. The Pharmacy Access Scheme provides additional funding to pharmacies in areas where there are fewer pharmacies. In rural areas where there are no pharmacies, general practices are permitted to dispense medicines. Patients can also choose to access medicines and pharmacy services through any of the nearly 400 NHS online pharmacies that are contractually required to deliver prescription medicines free of charge to patients.

Medicine supply chains are complex, global, and highly regulated, and there are a number of reasons why supply can be disrupted, many of which are not specific to the United Kingdom and outside of Government control, including manufacturing difficulties, difficulties in access to raw materials, sudden demand spikes or distribution issues, and regulatory issues. We have drawn on up-to-date intelligence and data on the root causes of medicine supply issues, with manufacturing problems being the most dominant root cause.

Most supply issues can be managed to avoid shortages, and while we can’t always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate the risks to patients.

The Department monitors and manages medicine supply at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual pharmacies is not held centrally.

The resilience of UK’s supply chains is a key priority, and the Department and NHS England are committed to helping to build long term supply chain resilience for medicines. We are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. The Department, working closely with NHS England, is taking forward a range of actions to improve our ability to mitigate and manage shortages and strengthen our resilience. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain as we progress work to co-design and deliver solutions.